Skip to main content
Grifols S.A. logo

Grifols S.A. — Investor Relations & Filings

Ticker · GRF ISIN · ES0171996087 LEI · 959800HSSNXWRKBK4N60 MC Manufacturing
Open in API
Filings indexed 684 across all filing types
Latest filing 2023-02-28 Annual Report
Country ES Spain
Listing MC GRF

About Grifols S.A.

https://www.grifols.com/en/home

Grifols S.A. is a global healthcare company specializing in the development, production, and marketing of plasma-derived medicines and other biopharmaceutical solutions. As a leading producer of therapies derived from human plasma, the company addresses the needs of patients with chronic, rare, and life-threatening conditions. Its core activities encompass the entire plasma value chain, from collection to the manufacturing of essential protein therapies. In addition to its primary Biopharma division, Grifols provides a comprehensive portfolio of diagnostic solutions for transfusion medicine and clinical laboratories, as well as bio supplies for pharmaceutical and research applications. The company is committed to advancing patient health and well-being through scientific innovation and high standards of quality and safety.

Recent filings

Filing Released Lang Actions
Annual Report 2022
Annual Report Classification · 95% confidence The document provides detailed financial statements (Balance Sheet) for Grifols, S.A. as of December 31, 2022. It includes comparative data for 2021 and references specific notes to the financial statements. Since this is a comprehensive financial report for a full fiscal year, it falls under the category of an Annual Report (10-K). FY 2022
2023-02-28 Spanish
Audit Report / Information 2022
Audit Report / Information Classification · 99% confidence The document is explicitly titled "Auditor's Report on Grifols, S.A. and subsidiaries" and contains sections like "Independent Auditor's Report on the Consolidated Annual Accounts," "Opinion," and detailed descriptions of "Key Audit Matters" related to goodwill impairment testing. This content is characteristic of a formal audit opinion accompanying the annual financial statements. While it relates to the full year ended 31 December 2022, which might suggest a 10-K, the primary focus and explicit title point directly to the Audit Report itself, which aligns best with the 'Audit Report / Information' category (AR). It is not the full Annual Report (10-K) but the auditor's opinion on it. FY 2022
2023-02-28 English
Annual Report 2022
Annual Report Classification · 100% confidence The document is titled 'CONSOLIDATED ANNUAL FINANCIAL REPORT' and includes a detailed auditor's report by KPMG on the consolidated annual accounts for the fiscal year ended 31 December 2022. It contains an auditor's opinion, key audit matters, and responsibilities of directors and auditors, all typical components of an annual report. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of detailed financial audit information and management declarations confirms this is the official yearly report covering company activity and full financial performance, consistent with an Annual Report (10-K) filing type. FY 2022
2023-02-28 Spanish
FORM 6-K
Regulatory Filings
2023-02-24 English
El Consejo de Administración ha acordado, en su reunión de fecha 23 de febrero de 2023, entre otros acuerdos, modificar el Reglamento del Consejo de Administración.
Governance Information Classification · 98% confidence The document is a formal communication from Grifols, S.A., dated February 24, 2023, reporting an agreement made by the Board of Directors on February 23, 2023. The core content is the modification of the 'Reglamento del Consejo de Administración' (Board of Directors Regulations), which is detailed in Annex I. This document outlines internal rules, the roles of the Chairman, the Lead Independent Director (Consejero Coordinador), and the Audit Committee (Comité de Auditoría). These topics—internal rules, board structure, and governance practices—are central to corporate governance documentation. The mention of SEC and NASDAQ requirements further confirms its nature as a governance filing. This aligns directly with the definition of Governance Information (CGR). It is not an earnings release (ER), an annual report (10-K), or a proxy statement (PSI), but rather a disclosure about the company's internal governance framework.
2023-02-24 Spanish
Corporate Governance Report - Grifols S.A.
Remuneration Information Classification · 99% confidence The document text explicitly discusses the 'POLÍTICA DE REMUNERACIONES DE LA SOCIEDAD' (Remuneration Policy of the Company) for directors and senior management. It details procedures, external advisors used (Mercer LLC, Willis Towers Watson), the structure of fixed vs. variable compensation, performance metrics (EBIT, ESG goals), and alignment with long-term interests. This content directly corresponds to the disclosure requirements for executive and director compensation, which falls under the Remuneration Information category. The filing date context (end of fiscal year 31/12/2022, discussing the policy for the current exercise 2023) suggests this is part of an annual disclosure related to governance and compensation, most closely matching the definition for Remuneration Information (DEF 14A in the US context, or the equivalent annual remuneration report in Spanish regulatory frameworks). It is not a general Annual Report (10-K) as it focuses narrowly on remuneration, nor is it a simple announcement (RPA/RNS) given its substantial length and detailed content.
2023-02-24 Spanish

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.